Bluebird stock surges after myeloma treatment impresses in tiny study

Shares of Bluebird were up more than 24 percent in premarket trade Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.